abrdn Life Sciences Investors
HQL
48 hedge funds and large institutions have $56.7M invested in abrdn Life Sciences Investors in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
9% more funds holding
Funds holding: 44 → 48 (+4)
1.09% more ownership
Funds ownership: 11.91% → 13.01% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $65M → $56.7M (-$8.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DA
Doliver Advisors
Houston,
Texas
|
+$1.36M |
| 2 |
Morgan Stanley
New York
|
+$1.01M |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$901K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$835K |
| 5 |
Citigroup
New York
|
+$770K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$585K |
| 2 |
LPL Financial
San Diego,
California
|
-$400K |
| 3 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$375K |
| 4 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$345K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$307K |
HQL Hedge Fund Activity: Q3 2015 in Review
48 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2015, worth a combined $56.7M — down 13% from $65M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new HQL positions and 5 closed out — a net gain of 4 holders — while 19 added to existing stakes and 12 trimmed.
The largest buyer was Doliver Advisors, opening a new position worth an estimated $1.36M. The largest seller was UBS Group, cutting an estimated $585K.
- 48 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2015, up from 44 in Q2 2015.
- Funds reported $56.7M of abrdn Life Sciences Investors stock for Q3 2015, down 13% quarter-over-quarter.
- 9 funds opened new abrdn Life Sciences Investors positions in Q3 2015 and 5 closed out, a net change of +4 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2015 was Doliver Advisors, an estimated $1.36M added.
- The largest abrdn Life Sciences Investors seller in Q3 2015 was UBS Group, an estimated $585K sold.
Based on aggregated 13F filings for Q3 2015.